differences between glp-1 medications Compare Options | Ozempic v Mounjaro | WeightWatchers The first weight loss drugs

In addition to GLP-1s now well-known ability to treat diabetes and obesity, Al-Aly and his team found connections between GLP-1 use and reduced risk of substance use disorders, suicidal ideation, seizures, dementia and Alzheimers disease, among many others

Tirzepatide also showed improvements in lipids and cardiovascular risk factors compared to dulaglutide 1.5 mg and placebo

Maternal GLP-1 receptor activation inhibits fetal growth

Some semaglutide programs include B12 in the compounded formulation specifically because of the increased risk of deficiency

Specifically, researchers discovered that the L cells found in the ileum, the final and longest part of the small intestine, release two important gut peptides: GLP-1 and peptide tyrosine tyrosine (PYY), both of which contribute to satiety and the regulation of appetite and food intake

FoodNavigators upcoming Global GLP-1 Disruption webinar, airing February 5, 2026 at 3pm GMT/10am EST, will examine how GLP-1 medications are influencing different categories, where disruption is already visible and where expectations may be running ahead of reality